QB Biotechnology Private Limited

QB Biotechnology Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24100MH2022PTC380800 Incorporated 19 April 2022 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME
Data last updated
Revenue · FY 2025
₹39.42 Cr
▲ 47% YoY
Net profit · FY 2025
₹2.45 Cr
Net margin 6.2%
EBITDA · FY 2025
₹3.98 Cr
EBITDA margin 10.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹3.5 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings

About QB Biotechnology Private Limited

Data last updated:

QB Biotechnology Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 April 2022.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2022PTC380800. Its GSTIN is 27AAACQ8194Q1ZI (Maharashtra).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sachin Rambabu Khandelwal and Archana Khandelwal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹39.42 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹2.45 Cr (net margin 6.2%) and EBITDA of ₹3.98 Cr (EBITDA margin 10.1%).

As per MCA filings, the company has open charges of ₹3.5 Cr on record.

QB Biotechnology Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0227935).

Company details

CIN U24100MH2022PTC380800
Registration Number 380800
Incorporation Date 19 April 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0227935

Recognitions & Rankings of QB Biotechnology

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-MH-18-0227935

Contact details

QB Biotechnology Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No 74 – 78 Silver Wood Bunglow Gorai Link Road, Nr. Gorai Bridge Sai Baba Temple Borivali (W), Mumbai, Maharashtra, India – 400091
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of QB Biotechnology Private Limited, buy the company report.

Comprehensive company report
QB Biotechnology Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of QB Biotechnology is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of QB Biotechnology Private Limited, buy the company report.

Financials of QB Biotechnology Private Limited

FY 2025 filings available

QB Biotechnology Private Limited reported revenue of ₹39.42 Cr (up 47% YoY) for FY 2025.

Revenue · FY 2025
₹39.42 Cr ▲ 47%
Net profit · FY 2025
₹2.45 Cr margin 6.2%
EBITDA · FY 2025
₹3.98 Cr margin 10.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 47%
EBITDA CAGR growth
1 year
▲ 52%

Revenue rose 47% in the latest year. EBITDA rose 52% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.98 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.45 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin10.1%
Net Profit Margin6.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of QB Biotechnology Private Limited, buy the company report.

Board of directors of QB Biotechnology Private Limited

QB Biotechnology has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sachin Rambabu KhandelwalDirector19 Apr 20224 Years 6 MonthsCurrent
Archana KhandelwalDirector19 Apr 20224 Years 6 MonthsCurrent

Auditor

QB Biotechnology Private Limited is audited by Dodhiya & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Dodhiya & Co.FY 2023125243W

Shareholding

The shareholding of QB Biotechnology Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of QB Biotechnology Private Limited, buy the company report.

Charges & borrowings

Open charges
₹3.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹3.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Oct 2023100805467Hdfc Bank Limited₹3.5 CrOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for QB Biotechnology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

QB Biotechnology Private Limited has 1 active EPFO establishment as of Apr 09, 2024.

Active EPFO establishments
1

GST

QB Biotechnology has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACQ8194Q1ZIMaharashtraActive20 Feb 2023

To see the full GST registrations and return filing status of QB Biotechnology Private Limited, buy the company report.

Recent activity

QB Biotechnology Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Archana Khandelwal was appointed as Director on 19 Apr 2022.

AGM
Qb Biotechnology Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Qb Biotechnology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 350.00 Lakh with Charge ID 100805467 was registered on 17 Oct 2023.
Appointed
Archana Khandelwal was appointed as Director.
Appointed
Sachin Rambabu Khandelwal was appointed as Director.
Incorporation
19 Apr 2022
Qb Biotechnology Private Limited was registered on 19 Apr 2022 with Roc Mumbai & aged 4 years 6 months as per MCA records.

Frequently asked questions

QB Biotechnology is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 April 2022 (4+ years old) and is registered under CIN U24100MH2022PTC380800.

QB Biotechnology has 2 current directors:

The latest financial statements of QB Biotechnology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of QB Biotechnology is 27AAACQ8194Q1ZI, registered in Maharashtra.

The CIN (Corporate Identification Number) of QB Biotechnology is U24100MH2022PTC380800. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

QB Biotechnology was incorporated on 19 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.

Archana Khandelwal was appointed as Director on 19 Apr 2022. Sachin Rambabu Khandelwal was appointed as Director on 19 Apr 2022.

Yes, QB Biotechnology is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0227935).

The registered office of QB Biotechnology is at Plot No 74 – 78 Silver Wood Bunglow Gorai Link Road, Nr. Gorai Bridge Sai Baba Temple Borivali W, Mumbai, Maharashtra, India – 400091.

QB Biotechnology operates in the pharma industry, in the pharmaceutical retailers and distributors segment.